gemcitabine
Gemcitabine is a drug used to treat Pancreatic Cancer, Breast Cancer, Bladder Cancer, and other conditions. Gemcitabine is being actively studied in 339 studies and prior, has been studied in 510.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Eli Lilly and Company | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | Xian-Jun Yu |
Hoffmann-La Roche | Memorial Sloan Kettering Cancer Center | Jun Ma, MD |
M.D. Anderson Cancer Center | Massachusetts General Hospital | PD Dr. med. Volker Heinemann |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Not yet recruiting
- Nasopharyngeal Carcinoma
- Recurrent or Metastatic
- KL-A167
- +3 more
- Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
2022-03-23
Mar 23, 2022P
Recruiting
- Breast Cancer
- Breast Neoplasms
- Gemcitabine
- +2 more
- Charlottesville, VirginiaUniversity of Virginia
2021-10-29
Oct 29, 2021A
Active, not recruiting
- Cholangiocarcinoma
- +3 more
- Durvalumab
- +3 more
- Hannover, GermanyMedizinische Hochschule Hannover, Klinik für Gastroenterologie,
2021-10-14
Oct 14, 2021G
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Immuncell-LC
- Gemcitabine
- Seoul, Daehak-ro, Jongno-gu, Korea, Republic ofSeoul National University Hospital
2021-11-18
Nov 18, 2021J
Not yet recruiting
- Pancreatic Cancer
- Adavosertib
- Gemcitabine
- Boston, MassachusettsDana-Farber Cancer Institute
2022-01-23
Jan 23, 2022S
Completed
- Metastatic Pancreatic Adenocarcinoma
- nab-paclitaxel
- +2 more
- Madrid, SpainSpanish Cooperative for Digestive Tumour Therapy (TTD)
2021-08-11
Aug 11, 2021R
Not yet recruiting
- Pancreatic Cancer
- SHR6390
- +2 more
- Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiaotong University School of Medicine
2022-01-10
Jan 10, 2022H
Completed
- Pancreatic Cancer
- +4 more
- Ascorbic Acid
- +3 more
- Scottsdale, ArizonaHonorHealth Research Institute
2022-02-10
Feb 10, 2022D
Recruiting
- Pancreatic Cancer
- Gemcitabine
- +3 more
- Boston, MassachusettsDana Farber Cancer Institute
2021-12-28
Dec 28, 2021U
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Gemcitabine
- Aurora, ColoradoChildren's Hospital Colorado
2022-01-31
Jan 31, 2022U
Completed
- Cervical Carcinoma
- Intensity Modulated Radiation Therapy (IMRT)
- +2 more
- La Jolla, CaliforniaMoores UC San Diego Cancer Center
2022-02-16
Feb 16, 2022C
Recruiting
- Recurrent Breast Carcinoma
- +5 more
- Gemcitabine
- +4 more
- Duarte, California
- +1 more
2022-02-17
Feb 17, 2022H
Active, not recruiting
- Unresectable Pancreatic Carcinoma
- Tocilizumab
- +2 more
- Herlev, Denmark
- +1 more
2022-03-15
Mar 15, 2022P
Not yet recruiting
- Pancreatic Cancer Metastatic
- +2 more
- SBP-101
- +3 more
- (no location specified)
2022-02-21
Feb 21, 2022M
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
- LY2880070
- Gemcitabine
- New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
2022-03-02
Mar 2, 2022U
Recruiting
- Urothelial Cancer of Renal Pelvis
- Urothelial Carcinoma Ureter
- sterile water irrigation
- Gemcitabine
- Dallas, TexasUniversity of Texas Southwestern Medical Center
2021-11-30
Nov 30, 2021A
Completed
- Advanced Solid Tumors
- veliparib (ABT-888)
- +2 more
- (no location specified)
2021-07-29
Jul 29, 2021S
Recruiting
- Pancreas Cancer
- Bethanechol
- +2 more
- New York, New YorkColumbia University Medical Center
2022-02-03
Feb 3, 2022J
Recruiting
- Advanced Pancreatic Adenocarcinoma
- +2 more
- Gemcitabine
- +2 more
- Beverly Hills, California
- +1 more
2022-02-07
Feb 7, 2022V
Active, not recruiting
- Pancreatic Ductal Adenocarcinoma
- Sarcoma
- Decitabine
- Gemcitabine
- Iowa City, IowaUniversity of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021M
Active, not recruiting
- Metastatic Urothelial Cancer
- Nivolumab
- +3 more
- Baltimore, Maryland
- +5 more
2021-09-07
Sep 7, 2021C
Recruiting
- Recurrent Pancreatic Cancer
- Tislelizumab
- +2 more
- Shanghai, ChinaChanghai Hospital
2021-05-25
May 25, 2021S
Completed
- Lung Cancer
- Pemetrexed
- Gemcitabine
- Nashville, TennesseeTennessee Oncology
2022-02-21
Feb 21, 2022D
Not yet recruiting
- Soft Tissue Sarcoma
- +5 more
- Ascorbate
- Gemcitabine
- Iowa City, IowaUniversity of Iowa Hospitals & Clinics
2021-12-20
Dec 20, 2021I
Completed
- Metastatic Solid Tumors
- aldoxorubicin
- gemcitabine
- Scottsdale, Arizona
- +1 more
2022-01-27
Jan 27, 2022